RadioRx Receives $3,950,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    800 W El Camino Real Mountain View, CA 94040
  • Company Description
    RadioRx’s focus is on the development of first-in-class compounds that affect capillary blood flow through the manipulation of cellular and blood levels of the free radical nitric oxide or NO and its downstream signaling pathways.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds from the offering will be used for general working capital. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy